mizoribine has been researched along with Bright Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manabe, S; Nagata, M; Nitta, K | 1 |
| Mii, A; Shimizu, A; Takada, D; Tsuruoka, S | 1 |
| Iwamura, C; Kameoka, Y; Kobayashi, S; Kusunoki, R; Nagao, T; Nakayama, T; Suzuki, K; Yumura, W | 1 |
| Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y | 1 |
| Fujio, K; Kanda, H; Kubo, K; Sakurai, K; Yamamoto, K | 1 |
| Abe, Y; Fuke, T; Hisano, M; Itabashi, K; Mikawa, T; Tsuji, Y; Watanabe, S | 1 |
| Arimura, Y; Kawashima, S; Yoshihara, K | 1 |
| Guo, HB | 1 |
| Chinda, J; Fujino, T; Hasebe, N; Kabara, M; Matsuki, M; Nakagawa, N | 1 |
| Fujita, T; Murakami, R; Nakamura, N; Shimada, M; Shimaya, Y; Yamabe, H | 1 |
| Hashimoto, Y; Hirayama, A; Hirayama, K; Kobayashi, M; Koyama, A; Nagase, S; Nagata, M; Shimizu, Y; Usui, J; Yamagata, K; Yoh, K | 1 |
| Kobayashi, Y; Masaki, Y; Shigematsu, H | 1 |
| Kamata, K; Kobayashi, Y; Masaki, Y; Okubo, M; Tanaka, T; Uchiyama, T | 1 |
| Ito, M; Okamoto, K; Suzuki, Y | 1 |
| Endo, T; Horata-Takahashi, E; Kamata, K; Kobayashi, Y; Kumano, K; Nakayama, Y; Okubo, M; Osakabe, T; Sato, K; Tamura, K | 1 |
| Hosono, S; Kato, K; Murakami, R; Muramatsu, M; Omote, A; Sano, H; Sugimoto, Y; Tanaka, H; Watanabe, Y | 1 |
| Abe, M; Shimizu, M; Shou, I; Tomino, Y; Tsuge, T | 1 |
| Akimoto, T; Ando, Y; Asano, Y; Ito, C; Kusano, E | 1 |
| Aozuka, S; Chen, XM; Kobayashi, Y | 1 |
3 review(s) available for mizoribine and Bright Disease
| Article | Year |
|---|---|
Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
Topics: Abatacept; Adjuvants, Immunologic; Calcineurin Inhibitors; Everolimus; Glomerulonephritis; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Podocytes; Ribonucleosides; Rituximab; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2018 |
[ANCA associated vasculitis and PRGN].
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Cyclophosphamide; Disease Progression; Glomerulonephritis; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Recurrence; Ribonucleosides; Vasculitis | 2009 |
Mesangial immunoglobulin A deposition and focal glomerulosclerosis in a renal transplant patient with nephrotic syndrome--Berger's disease alone or superimposition of focal glomerulosclerosis?
Topics: Cyclosporine; Diagnosis, Differential; Female; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Nephrotic Syndrome; Prednisolone; Ribonucleosides | 1993 |
1 trial(s) available for mizoribine and Bright Disease
| Article | Year |
|---|---|
Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Female; Glomerulonephritis; Humans; Male; Middle Aged; Pilot Projects; Purines; Renal Circulation; Ribonucleosides; Treatment Outcome; Vasculitis | 2004 |
15 other study(ies) available for mizoribine and Bright Disease
| Article | Year |
|---|---|
Proliferative glomerulonephritis with unusual microlamellar organized deposits related to monoclonal immunoglobulin G3 (IgG3) kappa.
Topics: Aged; Female; Glomerulonephritis; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunosuppressive Agents; Kidney Glomerulus; Prednisolone; Proteinuria; Ribonucleosides; Treatment Outcome | 2018 |
Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizorib
Topics: Animals; Antibodies; Antibodies, Antineutrophil Cytoplasmic; Chemokine CCL2; Disease Models, Animal; Female; Glomerulonephritis; Humans; Interleukin-6; Mice; Mice, Inbred C57BL; Peroxidase; Receptors, Interleukin-6; Ribonucleosides; T-Lymphocyte Subsets | 2013 |
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2015 |
Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide-resistant ANCA-associated glomerulonephritis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Biopsy; Cyclophosphamide; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Microscopic Polyangiitis; Middle Aged; Ribonucleosides; Tacrolimus; Treatment Outcome | 2017 |
Pharmacokinetic study of mizoribine in child-onset glomerulonephritis.
Topics: Adolescent; Area Under Curve; Child; Child, Preschool; Female; Glomerulonephritis; Half-Life; Humans; Immunosuppressive Agents; Male; Ribonucleosides | 2008 |
Acute allograft renal failure with marked hyperuricemia developing during mizoribine administration: a case report with review of the literature.
Topics: Acute Kidney Injury; Adult; Allopurinol; Cyclosporine; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisone; Renal Dialysis; Ribonucleosides; Sodium Bicarbonate; Transplantation, Homologous | 2010 |
Mizoribine for crescentic glomerulonephritis with sarcoidosis: effectiveness not only for urinalysis abnormalities but also for hilar lymph node enlargement.
Topics: Antibodies, Antineutrophil Cytoplasmic; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Function Tests; Lymph Nodes; Lymphatic Diseases; Middle Aged; Peroxidase; Prednisolone; Radiography, Thoracic; Ribonucleosides; Sarcoidosis; Treatment Outcome; Urinalysis | 2013 |
Mizoribine suppresses proliferation of rat glomerular epithelial cells in culture and inhibits increase of monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 stimulated by thrombin.
Topics: Animals; Anti-Inflammatory Agents; Cattle; Cell Proliferation; Chemokine CCL2; Chemokine CXCL2; Dose-Response Relationship, Drug; Epithelial Cells; Glomerulonephritis; Immunosuppressive Agents; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleosides; RNA, Messenger; Thrombin | 2012 |
Modification of crescentic Masugi nephritis in the rabbit by Bredinin, a new immunosuppressant.
Topics: Animals; Antibody Formation; Creatinine; Glomerulonephritis; Kidney Glomerulus; Proteinuria; Rabbits; Ribonucleosides; Time Factors | 1983 |
Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid mice.
Topics: Animals; Body Weight; Glomerulonephritis; Kidney; Kidney Function Tests; Life Expectancy; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Organ Size; Ribonucleosides; Spleen | 1984 |
Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine. (2) Effect on crescentic-type anti-GBM nephritis in rats.
Topics: Animals; Autoimmune Diseases; Azathioprine; Basement Membrane; Glomerulonephritis; Immunosuppressive Agents; Kidney Glomerulus; Male; Rats; Rats, Inbred Strains; Ribonucleosides | 1984 |
Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies -- related scleroderma renal crisis treated with double-filtration plasmapheresis.
Topics: Acute Kidney Injury; Antibodies, Antineutrophil Cytoplasmic; Anticoagulants; Autoimmune Diseases; Biopsy, Needle; Combined Modality Therapy; Dipyridamole; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Neutrophils; Peroxidase; Plasmapheresis; Prednisolone; Ribonucleosides; Scleroderma, Systemic | 1997 |
Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice.
Topics: Animals; B-Lymphocytes; Disease Models, Animal; Flow Cytometry; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Immunoglobulin A; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Proteinuria; Ribonucleosides | 1998 |
[Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Combined Modality Therapy; Drug Therapy, Combination; Glomerulonephritis; Humans; Immune Complex Diseases; Immunosuppressive Agents; Male; Methylprednisolone; Peroxidase; Plasma; Plasma Exchange; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Ribonucleosides; Treatment Outcome | 2000 |
[Suppressive effect of mizoribine on progression of bovine serum albumin nephritis in mice].
Topics: Animals; Antibody Formation; Antigen-Antibody Complex; Disease Models, Animal; Female; Glomerulonephritis; Immunosuppressive Agents; Mice; Ribonucleosides; Serum Albumin, Bovine | 1987 |